Literature DB >> 28088915

Evaluation of microRNA Stability in Plasma and Serum from Healthy Dogs.

Lars Enelund1, Lise N Nielsen1, Susanna Cirera1.   

Abstract

BACKGROUND: Early and specific detection of cancer is of great importance for successful treatment of the disease. New biomarkers, such as microRNAs, could improve treatment efficiency and survival ratio. In human medicine, deregulation of microRNA profiles in circulation has shown great potential as a new type of biomarker for cancer diagnostics. There are, however, few studies of circulating microRNAs in dogs. Extracellular circulating microRNAs have shown a high level of stability in human blood and other body fluids. Nevertheless, there are still important issues to be solved before microRNAs can be applied routinely as a clinical tool, one of them being their stability over time in media commonly used for blood sampling.
OBJECTIVE: Evaluation of the stability of microRNA levels in plasma and serum from healthy dogs after storage at room temperature for different time points before being processed.
METHODS: The levels of four microRNAs (cfa-let-7a, cfa-miR-16, cfa-miR-23a and cfa-miR-26a) known to be stably expressed from other canine studies, have been measured by quantitative real-time PCR (qPCR).
RESULTS: MicroRNA levels were found sufficiently stable for gene profiling in serum- and plasma stored at room temperature for 1 hour but not for samples stored at room temperature for 24 hours.
CONCLUSION: Storage at room temperature of serum and plasma samples intended for microRNA profiling should be kept for a minimum period of time before proceeding with RNA isolation. For the four microRNAs investigated in the present study, we did not find significant differences in microRNA levels between serum and plasma samples from the same time point. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Biomarker; canine; circulating; degradation; microRNA; plasma; serum; stability

Mesh:

Substances:

Year:  2017        PMID: 28088915     DOI: 10.2174/2211536606666170113124114

Source DB:  PubMed          Journal:  Microrna


  12 in total

1.  Values of circulating molecular biomarkers (microRNAs) for the evaluation of renal failure during urgent abdominal sepsis anaesthesia.

Authors:  Tomas Bukauskas; Monika Kairytė; Rytis Mickus; Loreta Puleikytė; Andrius Macas
Journal:  Acta Med Litu       Date:  2019

2.  Methodological considerations for measuring biofluid-based microRNA biomarkers.

Authors:  Brian N Chorley; Elnaz Atabakhsh; Graeme Doran; Jean-Charles Gautier; Heidrun Ellinger-Ziegelbauer; David Jackson; Tatiana Sharapova; Peter S T Yuen; Rachel J Church; Philippe Couttet; Roland Froetschl; James McDuffie; Victor Martinez; Parimal Pande; Lauren Peel; Conor Rafferty; Frank J Simutis; Alison H Harrill
Journal:  Crit Rev Toxicol       Date:  2021-05-26       Impact factor: 6.184

Review 3.  Circulating MicroRNAs As Potential Biomarkers for Veterinary Infectious Diseases.

Authors:  Hao Dong; Qiang Gao; Xiaowei Peng; Yu Sun; Tao Han; Bolin Zhao; Yufu Liu; Chuanbin Wang; Xiaohui Song; Jiajun Wu; Lin Yang
Journal:  Front Vet Sci       Date:  2017-11-01

Review 4.  Extracellular Vesicles: Evolutionarily Conserved Mediators of Intercellular Communication.

Authors:  Charlotte Lawson; Dory Kovacs; Elizabeth Finding; Emily Ulfelder; Virginia Luis-Fuentes
Journal:  Yale J Biol Med       Date:  2017-09-25

5.  Expression of microRNA-23b in patients with sepsis and its effect on leukocytes and the expression of E-selectin and ICAM-1.

Authors:  Hao Ou; Xianzhong Xiao; Yu Jiang; Yue Peng; Mingshi Yang; Min Gao
Journal:  Exp Ther Med       Date:  2018-09-18       Impact factor: 2.447

6.  Evaluation of fecal microRNA stability in healthy cats.

Authors:  Janne G Lyngby; Annemarie T Kristensen; Merete Fredholm; Lise N Nielsen; Susanna Cirera
Journal:  Vet Clin Pathol       Date:  2019-06-26       Impact factor: 1.180

Review 7.  MicroRNA: a novel implication for damage and protection against ionizing radiation.

Authors:  Yonglin Chen; Jian Cui; Yaqi Gong; Shuang Wei; Yuanyun Wei; Lan Yi
Journal:  Environ Sci Pollut Res Int       Date:  2021-02-03       Impact factor: 4.223

8.  Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.

Authors:  Qihua Chen; Na Deng; Ke Lu; Qiao Liao; Xiaoyan Long; Deming Gou; Fangfang Bi; Jinxia Zhou
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

9.  Comparison of miRNA quantitation by Nanostring in serum and plasma samples.

Authors:  Catherine Foye; Irene K Yan; Waseem David; Neha Shukla; Yacob Habboush; Lori Chase; Kristen Ryland; Vivek Kesari; Tushar Patel
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

10.  Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.

Authors:  Susanna Cirera; Emilie Ulrikka Andersen-Ranberg; Sille Langkilde; Maria Aaquist; Hanne Gredal
Journal:  Acta Vet Scand       Date:  2019-12-03       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.